In vitro evaluation of cellulose acetate hemodialyzer immobilized with heparin

Polymers for Advanced Technologies

Volumn 17, Issue 6, 2006, Pages 453-462

  Kung, Fu Chen ^a   Chou, Wen Li ^b   Yang, Ming Chien ^a  

^a NATIONAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^b NANYA INSTITUTE OF TECHNOLOGY   (Taiwan)

Author keywords

Cellulose acetate; Compatibility; Fibers; Heparin; Stabilization

Indexed keywords

BIOCOMPATIBILITY; BLOOD; CELLULOSE; COAGULATION; DIALYSIS; ESTERS; SULFURIC ACID;

CELLULOSE ACETATE HEMODIALYZER; HEMOCOMPATIBILITY; HEPARIN;

HEMODIALYZERS;

BIOCOMPATIBILITY; BLOOD; CELLULOSE; COAGULATION; DIALYSIS; ESTERS; HEMODIALYZERS; SULFURIC ACID;

ACETATE; CELLULOSE; COAGULATING; DIALYSIS;

EID: 33747692352     PISSN: 10427147     EISSN: 10991581     Source Type: Journal    
DOI: 10.1002/pat.734     Document Type: Article

References (38)

1. Tsuruta T, Hayashi T, Kataoka K, Ishihara K, Kimura Y. Biomedical Applications of Polymeric Materials. CRC Press: Boca Raton, FL, 1993.
2. Sirolli V, Stante SD, Stuard S, Liberato LD, Amoroso L, Cappelli P, Bonomini M. Biocompatibility and functional performance of a polyethylene glycol acid grafted cellulose membrane for hemodialysis. Int. J. Artif. Organs 2000; 23: 356-364.
3. Lipps B, Stewart R, Perkins H, Holmes G, McLain E, Rolfs M, Oja P. The hollow fiber artificial kidney. Trans. Am. Soc. Artif. Intern. Org. 1969; 13: 200-208.
4. Sivakumar M, Mohanasundaram AK, Mohan D, Balu K, Rangarajan R. Modification of cellulose acetate its characterization and application as an ultrafiltration. membrane. J. Appl. Polym. Sci. 1998; 67: 1939-1946.
5. Ye SH, Watanabe J, Iwasaki Y, Ishihara K. Novel cellulose acetate membrane blended with phospholipid polymer for hemocompatible filtration system. J. Membr. Sci. 2002; 210: 411-421.
6. Kolb G, Fischer W, Seitz R. Hemodialysis and blood coagulation: the effect of hemodialysis on coagulation factor XIII and thrombin-antithrombin III complex. Nephron. 1991; 58: 106-108(B).
7. Ishii Y, Yano S, Kanai H. Evaluation of blood coagulation fibrinolysis system in patients receiving chronic hemodialysis. Nephron. 1996; 73: 407-412(B).
8. Oyewumi LK, Cernovsky ZZ, Freeman DJ. Relation of blood counts during clozapine treatment to serum concentrations of clozapine and nor-clozapine. Can. J. Psychiat. 2002; 47: 257-261.
9. Felfernig-Boehm D, Salat A, Vogl SE, Murabito M, Felfernig M. Early detection of preeclampsia by determination of platelet aggregability. Thromb. Res. 2000; 98: 139-146.
10. George-Gay B, Parker K. Understanding the complete blood count with differential. J. Perianesth. Nurs. 2003; 18: 96-117.
11. Efeoglu C, Akcay YD, Erturk S. A modified method for preparing platelet-rich plasma: an experimental study. J. Oral Maxillofac. Surg. 2004; 62: 1403-1407.
12. Chenoweth DE, Ann NY. Complement activation in extra-corporeal circuits. Acad. Sci. 1987; 516: 306-313.
13. Maud B, Gorbet M, Sefton V. Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. Biomaterials 2004; 25: 5681-5703.
14. Janatova J, Cheung AK, Parker CJ. Biomedical polymers differ in their capacity to activate complement. Complement Inflamm. 1991; 8: 61-69.
15. Yang MC, Lin WC, Liu TY. Hemocompatibility of polyacrylonitrile dialysis membrane immobilized with chitosan and heparin conjugate. Biomaterials 2004; 25: 1947-1957.
16. Yang MC, Lin WC, Chiu CL. Surface modification and blood compatibility of heparinated polysulfone membrane via ozone-induced grafting. Polym. Adv. Technol. 2002; 14: 103-113.
17. Yang MC, Lin WC. Surface modification and blood compatibility of polyacrylonitrile membrane with immobilized chitosan-heparin conjugate. J. Polym. Res. 2002; 9: 201-206.
18. Kang IK, Kwon OH, Lee YM, Sung YK. Preparation and surface characterization of functional group-grafted and heparin-immobilized polyurethanes by plasma glow discharge. Biomaterials 1996; 17: 841-847.
19. Dorfner K. Ion Exchangers. Walter de Gruyter and Co.: Berlin, 1991; 331.
20. Yang MC, Tong JH. Loose ultrafiltration of proteins using hydrolyzed polyacrylonitrile hollow fiber. J. Membr. Sci. 1997; 132: 63-71.
21. Hu SG, Joe CH, Yang MC. Surface grafting of polyester fiber with chitosan and the antibacterial activity of pathogenic bacteria. J. Appl. Polym. Sci. 2002; 86: 2977-2983.
22. Lai KN, Wang AY, Ho K, et al. Use of low-dose low molecular weight heparin in hemodialysis. Am. J. Kidney Dis. 1996; 28: 721-726.
23. Combea C, Molisa E, Lucasa P, Rileyb R, Clarka. MM. The effect of CA membrane properties on adsorptive fouling by humic acid. J. Membr. Sci. 1999; 154: 73-87.
24. Bae JS, Seo EJ, Kang IK. Synthesis and characterization of heparinized polyurethanes using plasma glow discharge. Biomaterials 1999; 20: 529-537.
25. Absolom DR, Zingg W, Neumann AW. Protein adsorption to polymer particles: role of surface properties. J. Biomed. Mater. Res. 1995; 16: 593-599.
26. Lee JH, Lee HB. Platelet adhesion onto wettability gradient surfaces in the absence and presence of plasma proteins. J. Biomed. Mater. Res. 1998; 41: 304-311.
27. Winterton LC, Andrade JD, Feijen J, Kim SW. Heparin interaction with protein with protein-adsorbed surfaces. J. Coll. Interface Sci. 1986; 111: 314-342.
28. Dion I, Baquey C, Candelon B, Monties JR. Haemocompatibility of titanium nitride. Int. J. Artif. Organs 1992; 15: 617-621.
29. Branger B, Oules R, Treissede D, Balducchi JP, Michel F, Crastes de Paulet A, Treille M. Blood lines should be considered in studies of biocompatibility during acetate haemodialysis. Proc. Eur. Dial Transplant Assoc Eur. Ren. Assoc. 1985; 21: 162-166.
30. Craddock PR, Fehr J, Dalmasso AP, Brighan KL, Jacob HS. Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. J. Clin. Invest. 1977; 59: 879-888.
31. Dawes J. Measurement of the affinities of heparins, naturally occurring GAGs, and other sulfated polymers for antithrombin III and thrombin. Anal. Biochem. 1988; 174: 177-186.
32. Kazatchkine MD, Carreno MP. Activation of the complement system at the interface between blood and artificial surfaces. Biomaterials 1988; 9: 30-35.
33. Rousseau Y, Carreno MP, Poignet JL, Kazatchkine MD, Haeffner-Cavaillon N. Dissociation between complement activation, integrin expression and neutropenia during hemodialysis. Biomaterials 1999; 20: 1959-1967.
34. Hoenich NA, Woffindin C, Stamp S, Roberts SJ, Turnbull J. Synthetically modified cellulose: an alternative to synthetic membranes for use in haemodialysis. Biomaterials 1997; 18: 1299-1303.
35. Yanaelle R, Haeffner-Cavaillon N, Jean-Louis P, Alain M, Marie-Paule C. In vivo intracellular cytokine production by leukocytes during hemodialysis. Cytokine 2000; 12: 506-517.
36. Hoenich NA, Woffindin CM, John NS, Jorg V. Biocompatibility of membranes used in the treatment of renal failure. Biomaterials 1995; 16: 587-592.
37. Pekna MR, Larsson B, Formgren UR, Nilsson B. Complement activation by polymethyl methacrylate minimized by end-point heparin attachment. Biomaterials 1993; 14: 189-192.
38. Cheung AK, Park CJ, Janatova J, Brynda E. Modulation of complement activation on hemodialysis membranes by immobilized heparin. J. Am. Soc. Nephrol. 1992; 2: 1328-1337.